410 related articles for article (PubMed ID: 18177476)
1. Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):586-93. PubMed ID: 18177476
[TBL] [Abstract][Full Text] [Related]
2. Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Vascul Pharmacol; 2007 Jun; 46(6):463-9. PubMed ID: 17395547
[TBL] [Abstract][Full Text] [Related]
3. Effect of vasopressin on type IV collagen production in human mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Regul Pept; 2008 Apr; 147(1-3):60-6. PubMed ID: 18258315
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
Pharmacol Res; 2008 Feb; 57(2):142-50. PubMed ID: 18299204
[TBL] [Abstract][Full Text] [Related]
5. Effects of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells.
Tahara A; Tsukada J; Tomura Y; Momose K; Suzuki T; Yatsu T; Shibasaki M
Eur J Pharmacol; 2006 May; 538(1-3):32-8. PubMed ID: 16678155
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin induces human mesangial cell growth via induction of vascular endothelial growth factor secretion.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
Neuropeptides; 2011 Apr; 45(2):105-11. PubMed ID: 21196048
[TBL] [Abstract][Full Text] [Related]
7. Effects of high glucose on AVP-induced hyperplasia, hypertrophy, and type IV collagen synthesis in cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
Endocr Res; 2012; 37(4):216-27. PubMed ID: 22594926
[TBL] [Abstract][Full Text] [Related]
8. Binding and signal transduction characteristics of the nonpeptide vasopressin V1A receptor-selective antagonist YM218 in cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Kusayama T; Momose K; Taniguchi N; Suzuki T; Yatsu T; Shibasaki M
Pharmacology; 2006; 78(2):81-90. PubMed ID: 16966841
[TBL] [Abstract][Full Text] [Related]
9. [Studies on type IV collagen production in cultured mesangial cells].
Sawada T; Haneda M; Togawa M; Kikkawa R
Nihon Jinzo Gakkai Shi; 1996 Nov; 38(11):469-74. PubMed ID: 8958700
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells.
Ji L; Yin XX; Wu ZM; Wang JY; Lu Q; Gao YY
Phytother Res; 2009 Apr; 23(4):477-85. PubMed ID: 19003945
[TBL] [Abstract][Full Text] [Related]
11. Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances.
Kostrzewska A; Laudanski T; Steinwall M; Bossmar T; Serradeil-Le Gal C; Akerlund M
Acta Obstet Gynecol Scand; 1998 Jan; 77(1):3-7. PubMed ID: 9492709
[TBL] [Abstract][Full Text] [Related]
12. Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells.
Giannico G; Cortes P; Baccora MH; Hassett C; Taube DW; Yee J
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F57-65. PubMed ID: 16896180
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cGMP phosphodiesterase 5 suppresses matrix metalloproteinase-2 production in pulmonary artery smooth muscles cells.
Sun XZ; Li ZF; Liu Y; Fang P; Li MX
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):362-7. PubMed ID: 19793106
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
Yu X; Li C; Li X; Cai L
Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
[TBL] [Abstract][Full Text] [Related]
15. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
[TBL] [Abstract][Full Text] [Related]
16. Mesangial cell-matrix interactions: modulation of matrix expression in mesangial cells by extracellular matrices.
Sakatsume M; Saito A; Takeda T; Yamazaki H; Narita I; Nishi S; Nakagawa Y; Arakawa M
Exp Nephrol; 1995; 3(6):362-8. PubMed ID: 8528681
[TBL] [Abstract][Full Text] [Related]
17. Requirement for glutamine in the expression of alpha-actin and type IV collagen in mesangial cells.
Pithon-Curi TC; Sellitti DF; Curi R; Machado MM; Hirszel P; Doi SQ
Cell Biochem Funct; 2006; 24(3):217-21. PubMed ID: 15920703
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of vasopressin V1A receptors and activation of mitogen-activated protein kinase in rat mesangial cells cultured under high-glucose conditions.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2012 May; 39(5):438-46. PubMed ID: 22352691
[TBL] [Abstract][Full Text] [Related]
19. Arginine vasopressin stimulates human mesangial cell production of endothelin.
Bakris GL; Fairbanks R; Traish AM
J Clin Invest; 1991 Apr; 87(4):1158-64. PubMed ID: 2010532
[TBL] [Abstract][Full Text] [Related]
20. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
Serradeil-Le Gal C; Lacour C; Valette G; Garcia G; Foulon L; Galindo G; Bankir L; Pouzet B; Guillon G; Barberis C; Chicot D; Jard S; Vilain P; Garcia C; Marty E; Raufaste D; Brossard G; Nisato D; Maffrand JP; Le Fur G
J Clin Invest; 1996 Dec; 98(12):2729-38. PubMed ID: 8981918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
